J&J的DePuy获得MinMaxMedical Gemtrack技术的权利

2026-05-27 00:46

Johnson & Johnson (JNJ) unit DePuy Synthes has acquired certain rights to develop, manufacture, and commercialize Gemtrack technology from MinMaxMedical for its Joints business.
Gemtrack is a radiofrequency ("RF") tracking technology. "DePuy Synthes aims to bring first-to-market Radiofrequency miniature tracker technology across joint reconstruction procedures, with the potential to establish a new industry standard for integrated image-guided and robotic-assisted Joint surgery," the company said in a news release.
RF tracking such as Gemtrack "has the potential to eliminate the need for infrared cameras and line-of-sight dependence, reduce the reliance on invasive anchors, and enable continuous, highly accurate real-time tracking."
DePuy Synthes said Gemtrack can be applied to shoulder, hip, and knee procedures for navigation and robotic applications.

More on Johnson & Johnson